Authors:
Marque, V
Alhenc-Gelas, M
Plu-Bureau, G
Oger, E
Scarabin, PY
Citation: V. Marque et al., The effects of transdermal and oral estrogen/progesterone regimens on freeand total protein S in postmenopausal women, THROMB HAEM, 86(2), 2001, pp. 713-714
Authors:
Tardy-Poncet, B
Rayet, I
Damon, G
Alhenc-Gelas, M
Dutour, N
Lavocat, MP
Citation: B. Tardy-poncet et al., Protein C concentrates in a neonate with a cerebral venous thrombosis due to heterozygous type 1 protein C deficiency, THROMB HAEM, 85(6), 2001, pp. 1118-1119
Authors:
Oger, E
Alhenc-Gelas, M
Plu-Bureau, G
Mennen, L
Cambillau, M
Guize, L
Pujol, Y
Scarabin, PY
Citation: E. Oger et al., Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy - Time-dependent change in transdermal,but not oral estrogen users, THROMB RES, 101(2), 2001, pp. 35-43
Authors:
Baud, O
Picard, V
Durand, P
Duchemin, J
Proulle, V
Alhenc-Gelas, M
Devictor, D
Dreyfus, M
Citation: O. Baud et al., Intracerebral hemorrhage associated with a novel antithrombin gene mutation in a neonate, J PEDIAT, 139(5), 2001, pp. 741-743
Authors:
Meyer, G
Emmerich, J
Helley, D
Arnaud, E
Nicaud, V
Alhenc-Gelas, M
Aiach, M
Fischer, AM
Sors, H
Fiessinger, JN
Citation: G. Meyer et al., Factors v Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis, AM J MED, 110(1), 2001, pp. 12-15
Authors:
Arnaud, E
Nicaud, V
Poirier, O
Rendu, F
Alhenc-Gelas, M
Fiessinger, JN
Emmerich, J
Aiach, M
Citation: E. Arnaud et al., Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism, ART THROM V, 20(2), 2000, pp. 585-592
Authors:
Oger, E
Alhenc-Gelas, M
Plu-Bureau, G
Guize, L
Scarabin, PY
Citation: E. Oger et al., Plasma 17 beta estradiol is inversely correlated with circulating vascularcell adhesion molecule, THROMB HAEM, 84(6), 2000, pp. 1125-1125
Authors:
Lozinguez, O
Arnaud, E
Belec, L
Nicaud, V
Alhenc-Gelas, M
Fiessinger, JN
Aiach, M
Emmerich, J
Citation: O. Lozinguez et al., Demonstration of an association between Chlamydia pneumoniae infection andvenous thromboembolic disease, THROMB HAEM, 83(6), 2000, pp. 887-891
Authors:
Picard, V
Bura, A
Emmerich, J
Alhenc-Gelas, M
Biron, C
Houbouyan-Reveillard, LL
Molho, P
Labatide-Alanore, A
Sie, P
Toulon, P
Verdy, E
Aiach, M
Citation: V. Picard et al., Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene, BR J HAEM, 110(3), 2000, pp. 731-734
Authors:
Aiach, M
Nicaud, V
Alhenc-Gelas, M
Gandrille, S
Arnaud, E
Amiral, J
Guize, L
Fiessinger, JN
Emmerich, J
Citation: M. Aiach et al., Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk, ART THROM V, 19(6), 1999, pp. 1573-1576
Authors:
Scarabin, PY
Alhenc-Gelas, M
Oger, E
Plu-Bureau, G
Citation: Py. Scarabin et al., Hormone replacement therapy and circulating ICAM-1 in postmenopausal women- A randomised controlled trial, THROMB HAEM, 81(5), 1999, pp. 673-675
Authors:
Alhenc-Gelas, M
Arnaud, E
Nicaud, V
Aubry, ML
Fiessinger, JN
Aiach, M
Emmerich, J
Citation: M. Alhenc-gelas et al., Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes, THROMB HAEM, 81(4), 1999, pp. 506-510
Authors:
Le Cam-Duchez, V
Gandrille, S
Tregouet, D
Alhenc-Gelas, M
Emmerich, J
Fiessinger, JN
Borg, JY
Aiach, M
Citation: V. Le Cam-duchez et al., Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor VArg 506 to Gln mutation, BR J HAEM, 106(4), 1999, pp. 889-897
Authors:
Zawadzki, C
Gaveriaux, V
Trillot, N
Bauters, A
Watel, A
Alhenc-Gelas, M
Preudhomme, C
Jude, B
Citation: C. Zawadzki et al., Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: Two cases in a French family, THROMB HAEM, 80(6), 1998, pp. 1027-1028